Cargando…

A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer

OBJECTIVE: Personalized chemotherapy based on molecular biomarkers can maximize anticancer efficiency. We aim to investigate predictive biomarkers capable of predicting response to irinotecan-based treatment in gastric cancer. METHODS: We examined gene expression of APTX, BRCA1, ERCC1, ISG15, Topo1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Jie, Wei, Jia, Wang, Hao, Yue, Guofeng, Yu, Lixia, Yang, Yang, Xie, Li, Zou, Zhengyun, Qian, Xiaoping, Ding, Yitao, Guan, Wenxian, Liu, Baorui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639168/ https://www.ncbi.nlm.nih.gov/pubmed/23517622 http://dx.doi.org/10.1186/1479-5876-11-73

Ejemplares similares

Synergistic Anticancer Effects of Polyphyllin I and Evodiamine on Freshly-Removed Human Gastric Tumors
por: Yue, Guofeng, et al.
Publicado: (2013)

Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer
por: Shen, Jie, et al.
Publicado: (2014)

SULF2 Methylation Is Associated with In Vitro Cisplatin Sensitivity and Clinical Efficacy for Gastric Cancer Patients Treated with a Modified FOLFOX Regimen
por: Shen, Jie, et al.
Publicado: (2013)

The plasma levels of 12 cytokines and growth factors in patients with gastric cancer
por: Zou, Zhengyun, et al.
Publicado: (2018)

TAZ Is Highly Expressed in Gastric Signet Ring Cell Carcinoma
por: Yue, Guofeng, et al.
Publicado: (2014)

Plasma mRNA as liquid biopsy predicts chemo-sensitivity in advanced gastric cancer patients
por: Shen, Jie, et al.
Publicado: (2017)

Low dose irradiation increases adoptive cytotoxic T lymphocyte migration in gastric cancer
por: Du, Juan, et al.
Publicado: (2017)

Gastric metastasis from sphenoid sinus melanoma: A case report
por: ZHAO, LIANJUN, et al.
Publicado: (2015)

A three‐lncRNA expression signature associated with the prognosis of gastric cancer patients
por: Song, Peng, et al.
Publicado: (2017)

Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions
por: Xie, Li, et al.
Publicado: (2010)

Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer
por: Wang, Lin, et al.
Publicado: (2013)

Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines
por: Zou, Zhengyun, et al.
Publicado: (2012)

Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line
por: Yang, Yang, et al.
Publicado: (2015)

Intelligently Targeted Drug Delivery and Enhanced Antitumor Effect by Gelatinase-Responsive Nanoparticles
por: Li, Rutian, et al.
Publicado: (2013)

Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer
por: Yang, Liuting, et al.
Publicado: (2018)

Neoadjuvant chemotherapy followed by D2 gastrectomy and esophagojejunal Roux-en-Y anastomosis in gastric small cell carcinoma: A case report
por: XIN, KAI, et al.
Publicado: (2014)

The Herb Medicine Formula “Chong Lou Fu Fang” Increases the Cytotoxicity of Chemotherapeutic Agents and Down-Regulates the Expression of Chemotherapeutic Agent Resistance-Related Genes in Human Gastric Cancer Cells In Vitro
por: Liu, Yongping, et al.
Publicado: (2011)

Neoadjuvant chemoradiotherapy followed by liver transplantation is a promising treatment for patients with unresectable hilar cholangiocarcinoma: A case report
por: Wang, Jun, et al.
Publicado: (2019)

Reversion of pH-Induced Physiological Drug Resistance: A Novel Function of Copolymeric Nanoparticles
por: Li, Rutian, et al.
Publicado: (2011)

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
por: Ding, Naiqing, et al.
Publicado: (2019)

Disappearance of bone metastases in chemotherapy-resistant gastric cancer treated with antigen peptide-pulsed dendritic cell-activated cytotoxic T lymphocyte immunotherapy: A case report
por: Du, Juan, et al.
Publicado: (2018)

CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells for adoptive therapy
por: Su, Shu, et al.
Publicado: (2015)

Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy
por: Yue, Bei, et al.
Publicado: (2021)

Irinotecan Monotherapy Versus Irinotecan-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis
por: Cho, Yo-Han, et al.
Publicado: (2017)

Identification of a novel gene signature for the prediction of recurrence in HCC patients by machine learning of genome-wide databases
por: Shen, Jie, et al.
Publicado: (2020)

CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers
por: Liu, Shunli, et al.
Publicado: (2018)

MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT
por: Qian, Lingyu, et al.
Publicado: (2020)

Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma
por: Ding, Naiqing, et al.
Publicado: (2023)

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
por: Satoh, Taroh, et al.
Publicado: (2014)

Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer
por: Xu, Gui-fang, et al.
Publicado: (2014)

Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma
por: Di Lauro, L, et al.
Publicado: (2007)

Case Report: Neoadjuvant PD-1 Blockade Plus Concurrent Chemoradiotherapy in Unresectable Locally Advanced Gastric Cancer Patients
por: Wei, Jia, et al.
Publicado: (2021)

Herbal Medicines for Irinotecan-Induced Diarrhea
por: Tang, Liu, et al.
Publicado: (2019)

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
por: Wang, Lifeng, et al.
Publicado: (2008)

Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma
por: Park, S R, et al.
Publicado: (2006)

Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer
por: Aoki, Masahiko, et al.
Publicado: (2019)

Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
por: Li, Binghua, et al.
Publicado: (2017)

Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog
por: Gao, Guangyi, et al.
Publicado: (2018)

Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2017)

Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial
por: Wei, Jia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3lcl8ndo8a3idl2koa9rhg711o